Müller-Enoch D, Sato N, Thomas H
Hoppe Seylers Z Physiol Chem. 1981 Aug;362(8):1091-9. doi: 10.1515/bchm2.1981.362.2.1091.
Scoparone (6,7-dimethoxycoumarin) is demethylated to scopoletin (7-hydroxy-6-methoxycoumarin) and isoscopoletin (6-hydroxy-7-methoxycoumarin) by the cytochrome P-450-dependent monooxygenase system of rat liver microsomes. Under the conditions used, the ratio of scopoletin to isoscopoletin was determined to 1:1.8 +/- 0.1 for microsomes from untreated rats. Based on this reaction, a direct fluorometric method for the microsomal O-demethylation activity for scoparone is described. The fluorescence of the scopoletin formed in the incubation mixture is recorded after the adjustment of the excitation and emission wavelengths to 398 and 460 nm, respectively. The fluorescence of scoparone and isoscopoletin does not interfere with the test. Pretreatment of rats with phenobarbital or polycyclic hydrocarbons (3-metylcholanthrene, benzo[a]pyrene) causes a change in the ratio of the demethylation products scopoletin to isoscopoletin which was determined to be 1:2.5 +/- 0.1 (benzo[a]pyrene or 3-methylccholanthrene) or 1:5.9 +/- 0.01 (phenobarbital) respectively, and a significant increase in the amount of microsomal O-demethylation activity. Thus the ratio of the two products varies significantly with the state of induction. The difference spectra of scoparone with liver microsomes obtained from benzo[a]pyrene- and 3-methylcholanthrene-pretreated rats show an absorption peak at 416 nm and a trough at 393 nm with an isosbestic point at 405 nm. This scoparone-induced modified Type II spectral change seems to indicate the interaction of the 6- or 7-methoxy group of scoparone with the heme ion of the 394-nm form and its conversion into a modified ferrihemochrome with a absorption peak at 416 nm. This is modified ferrihemochrome is not identical with the 418-nm form of the cytochrome P-450.
滨蒿内酯(6,7 - 二甲氧基香豆素)被大鼠肝脏微粒体的细胞色素P - 450依赖的单加氧酶系统脱甲基化为东莨菪素(7 - 羟基 - 6 - 甲氧基香豆素)和异东莨菪素(6 - 羟基 - 7 - 甲氧基香豆素)。在所使用的条件下,对于未处理大鼠的微粒体,东莨菪素与异东莨菪素的比例测定为1:1.8±0.1。基于此反应,描述了一种用于测定滨蒿内酯微粒体O - 脱甲基化活性的直接荧光法。在将激发波长和发射波长分别调整为398和460 nm后,记录孵育混合物中形成的东莨菪素的荧光。滨蒿内酯和异东莨菪素的荧光不干扰该测试。用苯巴比妥或多环烃(3 - 甲基胆蒽、苯并[a]芘)预处理大鼠会导致脱甲基产物东莨菪素与异东莨菪素的比例发生变化,分别测定为1:2.5±0.1(苯并[a]芘或3 - 甲基胆蒽)或1:5.9±0.01(苯巴比妥),并且微粒体O - 脱甲基化活性显著增加。因此,这两种产物的比例随诱导状态有显著变化。从苯并[a]芘和3 - 甲基胆蒽预处理的大鼠获得的滨蒿内酯与肝脏微粒体的差示光谱在416 nm处有一个吸收峰,在393 nm处有一个谷,在405 nm处有一个等吸收点。这种滨蒿内酯诱导的II型光谱变化似乎表明滨蒿内酯的6 - 或7 - 甲氧基与394 - nm形式的血红素离子相互作用,并将其转化为在416 nm处有吸收峰的修饰高铁血红素。这种修饰的高铁血红素与细胞色素P - 450的418 - nm形式不同。